RA Session (Taysha)
In the heart of Texas, the AveXis crew gathers for another go at gene therapy with $30M and a powerhouse academic pact to start
The same week RA Session II closed the seed financing for his latest gene therapy startup — back in early March — the Dow dropped a couple …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
